Education
About Us
Working with TipRanks
Follow Us
Impact BioMedical, Inc. (IBO)
:IBO
IBO Stock Chart & Stats
$0.65
-$0.05(-2.70%)
At close: 4:00 PM EST
$0.65
-$0.05(-2.70%)
Day’s Range― - ―
52-Week Range$0.36 - $6.17
Previous Close$1.75
Volume10.40K
Average Volume (3M)174.82K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$1.32M
Total Debt (Recent Filing)$9.14M
Price to Earnings (P/E)―
Beta3.76
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.16
Shares Outstanding104,621,230
10 Day Avg. Volume124,357
30 Day Avg. Volume174,819
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)79.16
Price to Sales (P/S)144.63
P/FCF Ratio-86.02
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Impact BioMedical, Inc. News
IBO FAQ
What was Impact BioMedical, Inc.’s price range in the past 12 months?
Impact BioMedical, Inc. lowest stock price was $0.36 and its highest was $6.17 in the past 12 months.
What is Impact BioMedical, Inc.’s market cap?
Currently, no data Available
When is Impact BioMedical, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Impact BioMedical, Inc.’s earnings last quarter?
Currently, no data Available
Is Impact BioMedical, Inc. overvalued?
According to Wall Street analysts Impact BioMedical, Inc.’s price is currently Overvalued.
Does Impact BioMedical, Inc. pay dividends?
Impact BioMedical, Inc. does not currently pay dividends.
What is Impact BioMedical, Inc.’s EPS estimate?
Impact BioMedical, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Impact BioMedical, Inc. have?
Impact BioMedical, Inc. has 104,621,230 shares outstanding.
What happened to Impact BioMedical, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Impact BioMedical, Inc.?
Currently, no hedge funds are holding shares in IBO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Impact BioMedical, Inc.
Impact BioMedical Inc. engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. It provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. The company also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, it develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use in as health supplements and medications. The company was incorporated in 2018 and is based in Houston, Texas.
Technical Analysis
Scinai Immunotherapeutics
―
Clearside Biomedical
―
Aditxt
―
NewcelX
―
Virax Biolabs Group Ltd. Class A
―
Ownership Overview
0.09% Insiders
0.08% Mutual Funds
0.04% Other Institutional Investors
99.77% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---